• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchVeraxa Biotech AG
    Picture of Veraxa Biotech AG logo

    VRXA — Veraxa Biotech AG News Story

    $1.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapValue Trap
    • Market Cap
      $147.73m
    • Enterprise Value
      $147.70m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • VRXA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    VRXA Dividends
    All News

    NASDAQ RESUMED AT 10:15 AM

    Picture of Veraxa Biotech AG logoVeraxa Biotech AG
    11/06/2026 15:15
    NASDAQ RESUMED  AT 10:15 AM

    Recent news on Veraxa Biotech AG

    See all news
    • Brief: Veraxa Biotech Holding AG - Files To Register Resale Of Up To 25 Million Ordinary Shares - SEC Filing

      31/07/2026 22:19
    • Brief: Veraxa Biotech Shareholders Approve All Proposals At Extraordinary General Meeting, Strengthening Strategic Flexibility For Future Growth

      24/07/2026 22:31
    • Brief: Veraxa Biotech Initiates Cell Line Development With ATUM

      02/07/2026 13:32
    • NASDAQ RESUMED AT 01:08 PM

      16/06/2026 18:08
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM

      16/06/2026 16:24

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.